Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Morvaridi, Susan ^a   Dhall, Deepti ^a   Greene, Mark I ^b   Pandol, Stephen J ^a   Wang, Qiang ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WWTR1 PROTEIN, HUMAN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ACINAR CELL; ANIMAL; C57BL MOUSE; CHRONIC PANCREATITIS; CYTOLOGY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; PANCREAS CARCINOMA; PANCREAS ISLET; PANCREAS TUMOR; PANCREATIC STELLATE CELL; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ACINAR CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; PANCREATITIS, CHRONIC; PHOSPHOPROTEINS; UP-REGULATION;

EID: 84947709363     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16759     Document Type: Article

References (81)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. & Forman, D. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
2. Hidalgo, M. Pancreatic cancer. N Engl J Med 362, 1605-1617 (2010).
3. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J Clin 63, 11-30 (2013).
4. Ryan, D. P., Hong, T. S. & Bardeesy, N. Pancreatic adenocarcinoma. N Engl J Med 371, 1039-1049 (2014).
5. Witt, H., Apte, M. V., Keim, V. & Wilson, J. S. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 132, 1557-1573 (2007).
6. Lerch, M. M. & Gorelick, F. S. Models of acute and chronic pancreatitis. Gastroenterology 144, 1180-1193 (2013).
7. Apte, M., Pirola, R. & Wilson, J. New insights into alcoholic pancreatitis and pancreatic cancer. J Gastroenterol Hepatol 24, Suppl 3, S51-S56 (2009).
8. Erkan, M. et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 9, 454-467 (2012).
9. Zhao, B. et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25, 51-63 (2011).
10. Huang, J. M. et al. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the nonreceptor type protein tyrosine phosphatase 14. Oncogene 32, 2220-2229 (2013).
11. Cai, J., Zhang, N., Zheng, Y., De Wilde, R. F., Maitra, A. & Pan, D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24, 2383-2388 (2010).
12. Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24, 1106-1118 (2010).
13. Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772 (2011).
14. Zhao, B., Li, L., Lei, Q. & Guan, K. L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24, 862-874 (2010).
15. Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283, 5496-5509 (2008).
16. Basu, S., Totty, N. F., Irwin, M. S., Sudol, M. & Downward, J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11, 11-23 (2003).
17. Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21, 2747-2761 (2007).
18. Wang, W., Huang, J. & Chen, J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286, 4364-4370 (2011).
19. Chan, S. W., Lim, C. J., Chong, Y. F., Pobbati, A. V., Huang, C. & Hong, W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286, 7018-7026 (2011).
20. Liu, X. et al. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 32, 1266-1273 (2013).
21. Michaloglou, C. et al. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. PLoS One 8, e61916 (2013).
22. Wilson, K. E., Li, Y. W., Yang, N., Shen, H., Orillion, A. R. & Zhang, J. PTPN14 forms complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function. J Biol Chem 289, 23693-23700 (2014).
23. Poernbacher, I., Baumgartner, R., Marada, S. K., Edwards, K. & Stocker, H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol 22, 389-396 (2012).
24. Ogata, M. et al. Effects of overexpression of PTP36, a putative protein tyrosine phosphatase, on cell adhesion, cell growth, and cytoskeletons in HeLa cells. J Biol Chem 274, 12905-12909 (1999).
25. Wyatt, L., Wadham, C., Crocker, L. A., Lardelli, M. & Khew-Goodall, Y. The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol 178, 1223-1235 (2007).
26. Wadham, C., Gamble, J. R., Vadas, M. A. & Khew-Goodall, Y. The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. Mol Biol Cell 14, 2520-2529 (2003).
27. Inada, A. et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci USA 105, 19915-19919 (2008).
28. Hayashi, K. Y., Tamaki, H., Handa, K., Takahashi, T., Kakita, A. & Yamashina, S. Differentiation and proliferation of endocrine cells in the regenerating rat pancreas after 90% pancreatectomy. Arch Histol Cytol 66, 163-174 (2003).
29. Xu, X. et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132, 197-207 (2008).
30. Nagasao, J., Yoshioka, K., Amasaki, H. & Mutoh, K. Centroacinar and intercalated duct cells as potential precursors of pancreatic endocrine cells in rats treated with streptozotocin. Ann Anat 185, 211-216 (2003).
31. Gasslander, T., Ihse, I. & Smeds, S. The importance of the centroacinar region in cerulein-induced mouse pancreatic growth. Scand J Gastroenterol 27, 564-570 (1992).
32. Criscimanna, A. et al. Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology 141, 1451-1462, 1462 e1451-1456 (2011).
33. Inada, A., Nienaber, C., Fonseca, S. & Bonner-Weir, S. Timing and expression pattern of carbonic anhydrase II in pancreas. Dev Dyn 235, 1571-1577 (2006).
34. Reichert, M. & Rustgi, A. K. Pancreatic ductal cells in development, regeneration, and neoplasia. J Clin Invest 121, 4572-4578 (2011).
35. Trautmann, B., Schlitt, H. J., Hahn, E. G. & Lohr, M. Isolation, culture, and characterization of human pancreatic duct cells. Pancreas 8, 248-254 (1993).
36. Esposito, I. et al. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208, 673-685 (2006).
37. Hruban, R. H., Goggins, M., Parsons, J. & Kern, S. E. Progression model for pancreatic cancer. Clin Cancer Res 6, 2969-2972 (2000).
38. Maitra, A., Fukushima, N., Takaori, K. & Hruban, R. H. Precursors to invasive pancreatic cancer. Adv Anat Pathol 12, 81-91 (2005).
39. Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450 (2003).
40. Lugea, A., Nan, L., French, S. W., Bezerra, J. A., Gukovskaya, A. S. & Pandol, S. J. Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice. Gastroenterology 131, 885-899 (2006).
41. Xue, J. et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun 6, 7158 (2015).
42. Liu, Y. et al. Genetic inhibition of protein kinase Cepsilon attenuates necrosis in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 307, G550-563 (2014).
43. Rovira, M., Scott, S. G., Liss, A. S., Jensen, J., Thayer, S. P. & Leach, S. D. Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. Proc Natl Acad Sci USA 107, 75-80 (2010).
44. Furuyama, K. et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43, 34-41 (2011).
45. Kopp, J. L. et al. Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 138, 653-665 (2011).
46. Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737-750 (2012).
47. Manfroid, I. et al. Zebrafish sox9b is crucial for hepatopancreatic duct development and pancreatic endocrine cell regeneration. Dev Biol 366, 268-278 (2012).
48. Shroff, S. et al. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum Pathol 45, 456-463 (2014).
49. Song, S. et al. Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties. Cancer Res 74, 4170-4182 (2014).
50. Dor, Y., Brown, J., Martinez, O. I. & Melton, D. A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-46 (2004).
51. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to betacells. Nature 455, 627-632 (2008).
52. Sangiorgi, E. & Capecchi, M. R. Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis. Proc Natl Acad Sci USA 106, 7101-7106 (2009).
53. Gao, T. et al. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 144, 1543-1553, 1553 e1541 (2013).
54. George, N. M., Day, C. E., Boerner, B. P., Johnson, R. L. & Sarvetnick, N. E. Hippo signaling regulates pancreas development through inactivation of Yap. Mol Cell Biol 32, 5116-5128 (2012).
55. Llado, V. et al. Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of beta-Catenin and Yap by PKCzeta. Cell Rep 10, 740-754 (2015).
56. Bachem, M. G. et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907-921 (2005).
57. Zhou, D. et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 108, E1312-1320 (2011).
58. Imajo, M., Ebisuya, M. & Nishida, E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol 17, 7-19 (2015).
59. Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17, 2054-2060 (2007).
60. Mahoney, J. E., Mori, M., Szymaniak, A. D., Varelas, X. & Cardoso, W. V. The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors. Dev Cell 30, 137-150 (2014).
61. Lange, A. W., Sridharan, A., Xu, Y., Stripp, B. R., Perl, A. K. & Whitsett, J. A. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. J Mol Cell Biol 7, 35-47 (2015).
62. Yimlamai, D. et al. Hippo pathway activity influences liver cell fate. Cell 157, 1324-1338 (2014).
63. Beverdam, A., Claxton, C., Zhang, X., James, G., Harvey, K. F. & Key, B. Yap controls stem/progenitor cell proliferation in the mouse postnatal epidermis. J Invest Dermatol 133, 1497-1505 (2013).
64. Tang, Y., et al. MT1-MMP-dependent control of skeletal stem cell commitment via a beta1-integrin/YAP/TAZ signaling axis. Dev Cell 25, 402-416 (2013).
65. Tamm, C., Bower, N. & Anneren, C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 124, 1136-1144 (2011).
66. Zhang, W. et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci Signal 7, ra42 (2014).
67. Kapoor, A. et al. Yap1 activation enables bypass of oncogenic kras addiction in pancreatic cancer. Cell 158, 185-197 (2014).
68. Shao, D. D. et al. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival. Cell 158, 171-184 (2014).
69. Pandol, S. J., Gorelick, F. S., Gerloff, A. & Lugea, A. Alcohol abuse, endoplasmic reticulum stress and pancreatitis. Dig Dis 28, 776-782 (2010).
70. Fujii, M. et al. Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade. Cell Cycle 11, 3373-3379 (2012).
71. Ling, Q. et al. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 113, 38-48 (2004).
72. Krishnan, S., Deora, A. B., Annes, J. P., Osoria, J., Rifkin, D. B. & Hajjar, K. A. Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart. Dev Biol 265, 140-154 (2004).
73. Jacovina, A. T. et al. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest 119, 3384-3394 (2009).
74. Ortiz-Zapater, E. et al. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Am J Pathol 170, 1573-1584 (2007).
75. Zheng, L. et al. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 6, e19390 (2011).
76. Vishwanatha, J. K., Chiang, Y., Kumble, K. D., Hollingsworth, M. A. & Pour, P. M. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14, 2575-2579 (1993).
77. Diaz, V. M., Hurtado, M., Thomson, T. M., Reventos, J. & Paciucci, R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53, 993-1000 (2004).
78. Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M. & Kushner, J. A. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 12, 817-826 (2007).
79. Fendrich, V. et al. Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 135, 621-631 (2008).
80. Zulewski, H. et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50, 521-533 (2001).
81. Ardestani, A. et al. MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. Nat Med 20, 385-397 (2014).